Twitxy Saved

Kiran A. Kumar, MD, MBA

@kakumar86

Rad Onc @UTSW_RadOnc | Lymph/Peds/Sarc | Residency PD #MedEd | @StanfordRadOnc @BerkeleyHaas @UChicagoMed @UArizona Alum | AZ Sports Fan | Mixologist. Views=me
Dallas, TX utswmed.org/doctors/kiran-… Joined April 2017
922 Following 1.2K Followers 370 Posts

Latest posts 5

Kiran A. Kumar, MD, MBA @kakumar86
Yes he’s the best! Keep up the excellent mentorship @nbn426, we appreciate it :)
Neil Newman Verified account @nbn426 Sep 29
Nothing better than seeing a former medical student crush it with an oral and now part of the excellent program @UTSW_RadOnc - you are welcome @kakumar86 @NiuSanford @MonaArbabMD @aguilera_md ☺️☺️☺️🙌 @RKuehnleRadOnc
View quoted post on X
1 replies 0 reposts 15 likes 1.2K views View on X
Kiran A. Kumar, MD, MBA @kakumar86
That’s my resident! I guess now is as good of time as any to tell her we have her end of rotation lymphoma mock orals on Monday… seems like she’ll be just fine 😅
Having good coresidents is a real blessing &each of mine is amazing in their own way. This board in our resident room was Casey Moore’s idea. Weekly she spends a lot of time/energy updating it w/a new topic. Learned so much from this board. Thank you Casey for being so dedicated.
View quoted post on X
2 replies 0 reposts 17 likes 1.8K views View on X
Kiran A. Kumar, MD, MBA @kakumar86
My first clinical trial! While was just short of our hypothesis that early salvage ISRT after CAR-T can double CR rate from d30 to d90 PET, interesting subset and translative analyses forthcoming for when this could be great salvage option post-CAR-T (e.g. single site of PR)…
During a session on clinical trials shaping the future of RT, Dr. @kakumar86 presented his work, “Phase II Trial of ‘Re-Priming’ Radiation Therapy for Relapsed/Refractory Non-Hodgkin Lymphoma Patients in Incomplete Response after CAR-T Therapy.” #ASTRO25
View quoted post on X
3 replies 5 reposts 47 likes 6.1K views View on X
Kiran A. Kumar, MD, MBA @kakumar86
I swear there were people there (just empty front row)!

Happy to have presented our pos phase II clinical trial results from PROMISE, which has revolutionized our ability to safely (with built in gating as safety mech) treat young children (3-7) without sedation! #ASTRO25
To close out a day of fantastic research, our Chief of Peds and Lymphoma Radiation Oncology Services, Dr. @kakumar86 presented his work during the Best of Physics session about the PROMISE clinical trial to reduce anesthesia use in pediatric patients undergoing RT. #ASTRO25
View quoted post on X
2 replies 3 reposts 33 likes 5.1K views View on X
Kiran A. Kumar, MD, MBA @kakumar86
Very proud of @KhashiFattah for being one of four 2025 ROI award winners and being featured on the big stage at #ASTRO2025! @UTSW_RadOnc residents (only a PGY-2 at that) doing big things 👏🏾 @BobTimmermanMD @MonaArbabMD
Congratulations to Dr.@KhashiFattah! Dr. Fattah is a medical resident in our department.
View quoted post on X